Yan Ma

2.8k citations

74 papers · 2.2k indexed · 1 hit paper · h-index 23

Impact in

Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Nutrition and Dietetics top 5%
- Vitamin C and Antioxidants Research

Papers in ⓘ

Biomaterials 12
- Nanoparticle-Based Drug Delivery 12
Pharmaceutical Science 5
- Drug Solubulity and Delivery Systems 5

Co-authors: Jeanne Drisko (5 shared papers)Julia Chapman (1 shared paper)Mark Levine (1 shared paper)Kishore Polireddy (1 shared paper)Qi Chen (1 shared paper)Zhonggui He (8 shared papers)Yongjun Wang (8 shared papers)Xinglong Wang (1 shared paper)
Journals: Molecular Pharmaceutics (6 papers)Drug Delivery (3 papers)Scientific Reports (2 papers)ACS Applied Materials & Interfaces (2 papers)AAPS PharmSciTech (2 papers)
Partner nations: China United States Australia

In The Last Decade

Yan Ma

72 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy 2014 · 374 citations

Peers

Countries citing papers authored by Yan Ma

Since Specialization

Citations

This map shows the geographic impact of Yan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ma more than expected).

Fields of papers citing papers by Yan Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ma. The network helps show where Yan Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Yan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yan Ma Line = papers co-authored together Yan Ma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy Science Translational Medicine ·Yan Ma, Julia Chapman, Mark Levine, Kishore Polireddy, Jeanne Drisko, Qi Chen Hit paper breakdown →	2014	374
2	LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1 Human Molecular Genetics ·Xinglong Wang, Yan Ma, Hisashi Fujioka, Jinyue Liu, Amy L. Wilson‐Delfosse, Shu G. Chen, George Perry, Gemma Casadesús, Xuan Zhu	2012	333
3	Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines Nano Letters ·Yongjun Wang, Dan Liŭ, Qing‐Chuan Zheng, Qiang Zhao, Hongjuan Zhang, Yan Ma, John K. Fallon, Qiang Fu, Matthew T. Haynes, Guimei Lin, Rong Zhang, Dun Wang, Xinggang Yang, Linxiang Zhao, Zhonggui He, Feng Liu	2014	232
4	Multilayered epithelium in a rat model and human Barrett's esophagus: Similar expression patterns of transcription factors and differentiation markers BMC Gastroenterology ·Xiaoxin Chen, Rong Qin, Liu Ba, Yan Ma, Timothy Su, Chung S. Yang, Jonathan N. Glickman, Robert D. Odze, Nicholas J. Shaheen	2008	97
5	Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in Cancer Molecular Pharmaceutics ·Yan Ma, Dan Liu, Dun Wang, Yongjun Wang, Qiang Fu, John K. Fallon, Xinggang Yang, Zhonggui He, Feng Liu	2014	87
6	Paclitaxel–Paclitaxel Prodrug Nanoassembly as a Versatile Nanoplatform for Combinational Cancer Therapy ACS Applied Materials & Interfaces ·Xiangfei Han, Jinling Chen, Mengjuan Jiang, Na Zhang, Kexin Na, Cong Luo, Ruoshi Zhang, Mengchi Sun, Guimei Lin, Rong Zhang, Yan Ma, Dan Liŭ, Yongjun Wang	2016	73
7	Ligand-Modified Erythrocyte Membrane-Cloaked Metal–Organic Framework Nanoparticles for Targeted Antitumor Therapy Molecular Pharmaceutics ·Yixuan Lin, Yuping Zhong, Yongda Chen, Lin Li, Guoping Chen, Jiaxian Zhang, Pei Li, Chunhua Zhou, Yangwen Sun, Yan Ma, Zhi Xie, Qiongfeng Liao	2020	60
8	Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives Drug Delivery ·Tao Zhang, Ruyi Yang, Shengnan Yang, Jibin Guan, Dong Zhang, Yan Ma, Hongzhuo Liu	2018	55
9	Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers Acta Pharmaceutica Sinica B ·Meng Li, Liwen Zhao, Tao Zhang, Yue Shu, Zhonggui He, Yan Ma, Dan Liu, Yongjun Wang	2018	50
10	Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer Current Therapeutic Research ·Jun Yu, Yan Ma, Jeanne Drisko, Qi Chen	2013	44
11	Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer Molecular Pharmaceutics ·Mengjuan Jiang, Ruoshi Zhang, Yingli Wang, Wenna Jing, Ying Liu, Yan Ma, Bingjun Sun, Menglin Wang, Peizhuo Chen, Hongzhuo Liu, Zhonggui He	2017	44
12	Molecularly Imprinted Polymers with Enzymatic Properties Reduce Cytokine Release Syndrome ACS Nano ·Liuting Zhong, Junqiu Zhai, Yan Ma, Yihong Huang, Yongrui Peng, Yu-E Wang, Zhuo Peng, Hai‐Ling Gan, Zhongwen Yuan, Pengke Yan, Qingguo Li, Shixia Guan	2022	42
13	Differential gene expression in normal esophagus and Barrett’s esophagus Journal of Gastroenterology ·Jacob Wang, Rong Qin, Yan Ma, Huiyun Wu, Heiko Peters, Matthew J. Tyska, Nicholas J. Shaheen, Xiaoxin Chen	2009	38
14	Shape-Controlled Paclitaxel Nanoparticles with Multiple Morphologies: Rod-Shaped, Worm-Like, Spherical, and Fingerprint-Like Molecular Pharmaceutics ·Yongjun Wang, Dun Wang, Qiang Fu, Dan Liu, Yan Ma, Kelly Racette, Zhonggui He, Feng Liu	2014	38
15	Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1) International Journal of Nanomedicine ·Minzhi Zhao, Haiyun Li, Yan Ma, He Gong, Yang Shu, Qiaojun Fang, Zhiyuan Hu	2017	37
16	In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma Oncotarget ·Ziyan Y. Pessetto, Bin Chen, Hani Alturkmani, Stephen Hyter, Colleen Flynn, Michael Baltezor, Yan Ma, Howard G. Rosenthal, Kathleen Neville, Scott J. Weir, Atul J. Butte, Andrew K. Godwin	2016	33
17	Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor Molecular Cancer Therapeutics ·Ziyan Y. Pessetto, Yan Ma, Jeff Hirst, Margaret von Mehren, Scott J. Weir, Andrew K. Godwin	2014	32
18	Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system Drug Development and Industrial Pharmacy ·Yan Ma, Haigang Li, Shixia Guan	2014	31
19	Tumor Microenvironment-Responsive Theranostic Nanoplatform for Guided Molecular Dynamic/Photodynamic Synergistic Therapy ACS Applied Materials & Interfaces ·Dongyang Zhang, Fanglin Huang, Yan Ma, Guangzhong Liang, Zhuo Peng, Shixia Guan, Junqiu Zhai	2021	30
20	Carboplatin prodrug conjugated Fe₃O₄ nanoparticles for magnetically targeted drug delivery in ovarian cancer cells Journal of Materials Chemistry B ·Haiqin Song, Feifei Quan, Zhiqiang Yu, Minhua Zheng, Yan Ma, Haihua Xiao, Fang Ding	2018	28

About Yan Ma

Yan Ma is a scholar working on Biomaterials, Pharmaceutical Science, Aging, Complementary and Manual Therapy and Molecular Biology, having authored 74 papers that have together received 2.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (12 papers), Vitamin C and Antioxidants Research (5 papers), Drug Solubulity and Delivery Systems (5 papers), Photodynamic Therapy Research Studies (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Biomaterials (507 citations), Nutrition and Dietetics (289 citations), Pharmaceutical Science (96 citations), Neurology (238 citations) and Molecular Biology (916 citations). Yan Ma has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jeanne Drisko, Julia Chapman, Mark Levine, Kishore Polireddy, Qi Chen, Zhonggui He, Yongjun Wang, Xinglong Wang, Shu G. Chen and Gemma Casadesús. Their work appears in journals such as Molecular Pharmaceutics, Drug Delivery, Scientific Reports, ACS Applied Materials & Interfaces and AAPS PharmSciTech.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact